BioNTech

As many as 42,000 doses of the Moderna COVID-19 vaccine will arrive at the Cantacuzino Military Medicine Research and Development National Institute on Friday, according to the National COVID-19 Vaccination Coordination Committee (CNCAV).

There is not enough data to say for sure "how well the AstraZeneca/Oxford vaccine would work" in people over 55, and the reason for this is that most of the participants in the manufacturer's preliminary studies are between 18 and 55 years old.

The European Union put on a brave face on Feb. 1, defending its troubled vaccination programme and insisting that renewed pledges of vaccine deliveries would make up for a production shortfall.

Gregory Gregoriadis, an 86-year-old Greek scientist, was vaccinated against the novel coronavirus with the Pfizer/BioNTech jab at a UK medical center in Northwood, Middlesex just a few days ago.

This morning, 17,550 doses of Pfizer/BioNTech vaccine arrived in Bulgaria. The shipment will be distributed to all vaccination sites accross the country. This is the next in a planned series vaccine shipment received in our country. The last one arrived last week and contained 14,000 doses.

The European Union on Jan. 29 backtracked on a threat to restrict exports of coronavirus shots to Northern Ireland in its growing row with Britain, as the WHO warned against "vaccine nationalism".

The European Medicines Agency says no new side effects linked to the coronavirus vaccine made by BioNTech and Pfizer - and used in Greece right now - were identified in the regulator's first safety update on Covid-19 vaccines.

The European Medicines Agency is now recommending that a second dose of Pfizer's Covid-19 vaccine be given three weeks after the first, as many countries consider ways to stretch scarce supplies of shots.

EU demands that AstraZeneca make up delays of its COVID-19 vaccine by supplying doses from its U.K. factories on Jan. 27 risked setting the bloc and Britain on a post-Brexit collision course.

According to previous data, the EU managed to administer about 8.9 million doses, or two doses per 100 inhabitants. The United States and Great Britain have so far vaccinated seven, that is to say, 10.5 inhabitants per 100, respectively, and Israel is currently at 43.